Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Azenta -- Ignore unavailable to you. Want to Upgrade?

To: robert b furman who wrote (1005)	12/1/2016 12:13:08 PM
From: richardred	Read Replies (1) \| Respond to of 1138

I was one of the profit takers Bob. I sold out my weighted position. I very much like the life science division. The Cool acquisition builds on that. It's has me thinking BRKS might get a very good offer down the road for the life science division, and not the whole company. Something along the lines of Cree/Wolfspeed. >Question is do you get on board if the current retrace reverses at the 50 ($14.74)or 61.8 ($14.28) retrace? I'll have to look at Don's book to bill ratio. <G> . I think it's within reason. I also think a upward surprise is possible next QTR. This leading to a possible analysts upward revisions and setting the stage for a new breakout high. In stocks I've been in before. I generally watch those stocks for opportunities. Especially ones I've made money on, like BRKS